Carlos Guillén

Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors

B. Llombart, Carlos Monteagudo, Onofre Sanmartín et al. · Journal of the American Academy of Dermatology · 2011 · 135 citations

Medicine, Oncology, Pathology +16

Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (<i>COL1A1‐PDGFB </i>) study with therapeutic implications

B. Llombart, Onofre Sanmartín, José Antonio López‐Guerrero et al. · Histopathology · 2009 · 101 citations · Full text

Medicine, Oncology, Pathology +17

Molecular diagnosis of dermatofibrosarcoma protuberans: A comparison between reverse transcriptase‐polymerase chain reaction and fluorescence in situ hybridization methodologies

Rocío Salgado, B. Llombart, Ramón M. Pujol et al. · Genes Chromosomes and Cancer · 2011 · 97 citations

Medicine, Molecular Genetics, Pathology +13

A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: Clinical and histologic outcomes

C. Serra‐Guillén, Eduardo Nagore, L. Hueso et al. · Journal of the American Academy of Dermatology · 2012 · 81 citations

Medicine, Dermatology, Ophthalmology +12

Frequent <i>DPH3</i> promoter mutations in skin cancers

Evgeniya Denisova, Barbara Heidenreich, Eduardo Nagore et al. · Oncotarget · 2015 · 72 citations · Full text

Medicine, Dermatology, Oncology +14